| Model Number: | M6 |
| Moq: | 1 |
| Payment Terms: | T/T,L/C |
6-Channel Dry Fluorescence POCT Analyzer
| Test Items | |||
| Category | Abbreviation | Full Name | Clinical Significance |
| Cardiovascular | cTnI | Cardiac Troponin I | Preferred marker for myocardial injury; MI diagnosis. |
| CK-MB | Creatine Kinase-MB | Diagnoses acute myocardial infarction; monitors re-infarction. | |
| Myo | Myoglobin | Early diagnosis of MI; rules out MI in suspected patients. | |
| NT-proBNP | N-terminal Pro-brain Natriuretic Peptide | Detects acute/chronic heart failure; evaluates prognosis. | |
| BNP | Brain Natriuretic Peptide | Detects acute/chronic heart failure; evaluates prognosis. | |
| H-FABP | Heart-type Fatty Acid-binding Protein | Early diagnosis of MI; monitors re-infarction and thrombosis. | |
| D-Dimer | D-Dimer | Rules out pulmonary embolism and deep vein thrombosis. | |
| MPO | Myeloperoxidase | Predicts coronary artery disease risk; evaluates cardiovascular events. | |
| hs-CRP | High-sensitivity C-reactive Protein | Evaluates cardiovascular disease risk; indicates neonatal infection. | |
| Lp-PLA2 | Lipoprotein-associated Phospholipase A2 | Evaluates atherosclerosis and thrombotic disease risk. | |
| ST2 | Soluble Growth Stimulation Expressed Gene 2 | Screens high-risk heart failure; evaluates prognosis. | |
| S100β | S100 Beta | Evaluates brain injury severity; indicates long-term prognosis. | |
| H-FABP/MPO | Heart-type Fatty Acid-binding Protein / Myeloperoxidase | Early warning predictor for acute myocardial infarction. | |
| cTnI/CK-MB/Myo | Cardiac Troponin I / Creatine Kinase-MB / Myoglobin | Diagnoses acute myocardial infarction. | |
| cTnI/NT-proBNP | Cardiac Troponin I / N-terminal Pro-brain Natriuretic Peptide | Early diagnosis and evaluation of chronic heart failure. | |
| cTnI/H-FABP | Cardiac Troponin I / Heart-type Fatty Acid-binding Protein | Predicts adverse cardiovascular events; detects recurrent MI. | |
| Ox-LDL | Oxidized Low-density Lipoprotein | Evaluates coronary heart disease severity and prognosis. | |
| CPP | Copeptin | Rules out acute MI; monitors heart failure and stroke. | |
| Hcy | Homocysteine | Evaluates cardiovascular disease risk; monitors treatment efficacy. | |
| Infection & Inflammation | IL-6 | Interleukin-6 | Early marker of infection; severity & prognosis of sepsis. |
| PCT | Procalcitonin | Early marker of bacterial infection; guides antibiotic use. | |
| CRP | C-reactive Protein | Diagnosis of inflammation and infection. | |
| SAA | Serum Amyloid A | Early diagnosis of infection; efficacy evaluation. | |
| hs-CRP+CRP | High-sensitivity CRP / CRP | Infection type differentiation; monitors antibiotic efficacy. | |
| HBP | Heparin-binding Protein | Predicts bacterial infection severity; guides antibiotic use. | |
| SAA/CRP | Serum Amyloid A / C-reactive Protein | Early identification of viral/bacterial infections. | |
| IL-6/PCT | Interleukin-6 / Procalcitonin | Combined diagnosis and prognosis of sepsis. | |
| HNL | Neutrophil Lipocalin | Differentiates bacterial/viral infections; predicts sepsis. | |
| Maternal & Child Health | LH | Luteinizing Hormone | Evaluates ovarian/testicular function; ovulation detection. |
| Ferritin | Ferritin | Auxiliary diagnosis of iron deficiency anemia/tumors. | |
| PLGF | Placental Growth Factor | Monitors preeclampsia; evaluates liver cancer efficacy. | |
| sFlt-1 | Soluble fms-like Tyrosine Kinase 1 | Monitors preeclampsia; clinical decision support. | |
| IGFBP-1 | Insulin-like Growth Factor Binding Protein-1 | Auxiliary diagnosis of premature rupture of membranes. | |
| 25-OH-VD | 25-Hydroxyvitamin D | Auxiliary diagnosis of vitamin D deficiency. | |
| β-HCG | Beta-Human Chorionic Gonadotropin | Auxiliary diagnosis of ectopic pregnancy/early pregnancy. | |
| AMH | Anti-Müllerian Hormone | Marker of ovarian reserve; reflects antral follicle count. | |
| AFP | Alpha-fetoprotein | Evaluates abnormal pregnancy and Down syndrome risk. | |
| Prog | Progesterone | Auxiliary diagnosis of threatened abortion. | |
| Gastric Function | PGI | Pepsinogen I | Screens atrophic gastritis and gastric cancer risk. |
| PGII | Pepsinogen II | Initial screening indicator for atrophic gastritis/cancer. | |
| PGI/PGII | Pepsinogen I / Pepsinogen II | Monitors H. pylori treatment; screens gastric cancer. | |
| G-17 | Gastrin-17 | Evaluates gastric function with Pepsinogens. | |
| Pepsin | Pepsin | Objective basis for gastroesophageal reflux diagnosis. | |
| Renal Function | NGAL | Neutrophil Gelatinase-associated Lipocalin | Early diagnosis of acute kidney injury; prognosis. |
| Cys C | Cystatin C | Detects kidney injury; assesses glomerular damage. | |
| β2-MG | Beta-2 Microglobulin | Reflects renal tubular function; kidney damage marker. | |
| RBP | Retinol-binding Protein | Screens kidney function injury; differentiates liver/kidney syndromes. | |
| mAlb | Microalbumin | Auxiliary diagnosis of kidney diseases. | |
| Thyroid Function | TSH | Thyroid-stimulating Hormone | Diagnoses thyroid abnormalities; checks pituitary function. |
| TT3/TT4 | Total T3 / Total T4 | Routine indicator for hyperthyroidism/hypothyroidism. | |
| TT4 | Total Thyroxine | Screens hyperthyroidism/hypothyroidism; monitors TSH suppression. | |
| TT3 | Total Triiodothyronine | Screens hyperthyroidism/hypothyroidism; monitors TSH suppression. | |
| Tumor Markers | PRL | Prolactin | Evaluates pituitary/prolactinoma and endocrine disorders. |
| CEA | Carcinoembryonic Antigen | Assists malignant tumor diagnosis; differentiates benign/malignant. | |
| Glucose Metabolism | ADPN | Adiponectin | Differentiates pre-diabetes; monitors diabetic complications. |
| HbA1c | Glycated Hemoglobin | Diagnoses diabetes; monitors blood glucose control. | |
| Pulmonary Function | VEGF | Vascular Endothelial Growth Factor | Auxiliary diagnosis of chronic obstructive pulmonary disease. |

Q: How fast can test results be obtained?
Results are available in 3 to 15 minutes depending on the specific assay panel. This rapid turnaround enables immediate clinical decision-making in emergency and urgent care settings.
Q: What sample types can be used with this analyzer?
It supports whole blood, serum and plasma samples. Minimal pre-analytical sample preparation is required, making it well suited for point-of-care and near-patient testing environments.
Q: Can the analyzer connect to hospital information systems?
Yes. It features built-in wireless connectivity including WiFi, 4G and GPRS. Test results can be automatically uploaded to hospital LIS/HIS systems for centralized record-keeping and remote clinical review.